Skip to content

Why is the roll-out of injectable PrEP taking so long?

Tutatamafilm/Shutterstock.com

Almost two-thirds of new HIV cases occur outside southern and eastern Africa

A Liberian student being tested for HIV. Image by Bill Diggs. Creative Commons licence.

People who inject drugs in the US are more aware of PrEP, but aren’t taking it

Dr Patrick Eustaquio at CROI 2024. Photo by Krishen Samuel.

Top 5 stories on injectable HIV treatment and PrEP from CROI 2024

Dr Moses Kamya, lead researcher on the study on PrEP choices in Africa, at CROI 2024. Photo by Roger Pebody.

Top 5 HIV PrEP stories from CROI 2024

Dr Brenda Mirembe, lead researcher on the INSIGHT PrEP study, at CROI 2024. Photo by Roger Pebody.

Huge increase in PrEP uptake when services offer choice, flexibility and injectable PrEP, African study shows

Dr Moses Kamya at CROI 2024. Photo by Roger Pebody.

Far fewer HIV infections in Australian PrEP users – consistent use is key

Dr Nicholas Medland at CROI 2024. Photo by Roger Pebody.

HIV diagnoses continue to fall in US states with high PrEP coverage, while others are left behind

Dr Patrick Sullivan at CROI 2024. Photo by Roger Pebody.

PrEP marketing should not be a story about HIV, but a story about young women

Potential social marketing materials tested as part of the research process.